Myovant Sciences Ltd Revenue per Employee (MYOV), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Myovant Sciences Ltd   (NYSE: MYOV)
 

Myovant Sciences Ltd 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 84.11% in the third quarter 2023, year on year to cumulative value of $379 million, Myovant Sciences Ltd 's revenue per employee grew on a trailing twelve months basis to $ 1,267,933, this is below the company average.
Within the Healthcare sector Employees of 53 other companies have achieved higher revenue per employee. While Myovant Sciences Ltd 's total ranking has deteriorated compared to the previous quarter from 0 to 746. Myovant Sciences Ltd has 299 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MYOV Revenue per Employee (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter
Y / Y Revenue Change 84.11 % 34.56 % 183.69 % 133.96 % 3847.79 %
Sales per Employee (TTM) $ 1,267,933 1,114,793 1,024,753 772,482 662,241
MYOV's Total Ranking # 746 # 0 # 0 # 0 # 0
Seq. Revenue Change -4.38 % -10.02 % 102.36 % 5.74 % -30.12 %

MYOV Company Profile >> Back to MYOV Efficiency Comparisons >> Compare MYOV Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 28
Healthcare Sector # 54
Overall Market # 746

Revenue per Employee Statistics
High Average Low
$ 842,471 $ 589,914 $ 322,109
(Dec 31 2022)   (Sep 30 2021)



Financial Statements
Myovant Sciences Ltd 's Revenue MRQ $ 100 Millions Visit MYOV's Income Statement
Myovant Sciences Ltd 's Revenues TTM $ 379 Millions Visit MYOV's aggregate revenue growth
What are MYOV's Sales? Visit MYOV's Sales by Segment




Other Ratios
Myovant Sciences Ltd 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MYOV's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MYOV's Competitors
Revenue per Employee for MYOV's Suppliers
Revenue per Employee for MYOV's Customers

You may also want to know
MYOV's Sales Growth Rates MYOV's Pe Price to earnings ratio MYOV's Receivables Turnover Ratio MYOV's Stock Quote
MYOV's Net Income Growth Rates MYOV's Ps Price to Sales ratio MYOV's Sales per Employee MYOV's Asset Turnover Ratio
MYOV's Net Margin MYOV's Pb Price to Book ratio MYOV's Financial Strength Ratios MYOV's Dividend Payout Ratio
Date modified: 2026-08-29T17:37:43+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2022Number of Employees Dec 31 2022
Spero Therapeutics Inc   2,140,360.00 $ 53.509  Million 25 
Sorrento Therapeutics Inc   2,094,666.67 $ 62.840  Million 30 
Arbutus Biopharma Corp  2,053,631.58 $ 39.019  Million 19 
Innoviva Inc   2,030,672.96 $ 322.877  Million 159 
Maravai Lifesciences Holdings Inc   2,029,887.36 $ 883.001  Million 435 
Amgen Inc   2,024,846.15 $ 26,323.000  Million 13,000 
Petros Pharmaceuticals inc   1,997,356.33 $ 5.992  Million 3 
Prestige Consumer Healthcare Inc   1,945,249.12 $ 1,108.792  Million 570 
Shockwave Medical Inc   1,935,703.56 $ 489.733  Million 253 
Elutia Inc   1,891,807.69 $ 49.187  Million 26 
Scilex Holding Company  1,886,735.29 $ 64.149  Million 34 
Arcturus Therapeutics Holdings Inc   1,855,846.85 $ 205.999  Million 111 
Semler Scientific inc   1,828,580.65 $ 56.686  Million 31 
Adc Therapeutics Sa  1,813,564.77 $ 350.018  Million 193 
Marker Therapeutics inc   1,802,708.80 $ 9.014  Million 5 
Iteos Therapeutics Inc   1,704,649.68 $ 267.630  Million 157 
Xeris Biopharma Holdings Inc   1,696,123.08 $ 110.248  Million 65 
Seagen Inc   1,635,343.33 $ 1,962.412  Million 1,200 
Gilead Sciences Inc   1,604,764.71 $ 27,281.000  Million 17,000 
Zymeworks Inc   1,562,431.82 $ 412.482  Million 264 
Halozyme Therapeutics Inc   1,560,557.92 $ 660.116  Million 423 
Galapagos Nv  1,550,448.22 $ 565.914  Million 365 
Akebia Therapeutics Inc   1,507,649.48 $ 292.484  Million 194 
Harmony Biosciences Holdings inc   1,494,385.67 $ 437.855  Million 293 
Ispecimen inc   1,486,043.29 $ 10.402  Million 7 
Cartesian Therapeutics Inc   1,477,026.67 $ 110.777  Million 75 
Nektar Therapeutics  1,461,190.48 $ 92.055  Million 63 
Molecular Partners Ag  1,458,461.54 $ 189.600  Million 130 
Coherus Oncology inc   1,435,659.86 $ 211.042  Million 147 
Bristol myers Squibb Company  1,420,276.92 $ 46,159.000  Million 32,500 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.